Global Skin Treatment Markets Forecast Rapid Growth Through 2030s

Two market research reports project strong expansion in skin‑related treatment sectors. The global skin‑cancer treatment market was valued at approximately USD 8.2 billion in 2019 and is expected to reach about USD 21.1 billion by 2032, reflecting a compound annual growth rate of 7.5%. North America accounted for the largest share at 39.4% in 2019. The report highlights the role of major pharmaceutical companies such as Merck, Bristol‑Myers Squibb, Novartis, Roche, Amgen, GlaxoSmithKline, Pfizer and Sun Pharma, and notes ongoing product launches, partnerships and regulatory developments.

The skin‑tears treatment market, valued at USD 57.8 million in 2022, is projected to grow to USD 79.1 million by 2030, a CAGR of 4.0%. Growth is driven by the rising prevalence of skin tears among the elderly and increased adoption of advanced wound‑care products. Key players include Smith & Nephew, 3M, ConvaTec, Cardinal Health, Medline, Medtronic and others. Both reports emphasize regional market dynamics across North America, Europe, Asia‑Pacific and other regions.